Publisher
Springer Science and Business Media LLC
Reference206 articles.
1. Jalencas, X. & Mestres, J. On the origins of drug polypharmacology. MedChemComm 4, 80–87 (2013).
2. Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl Med. 9, eaag1166 (2017).
3. Dai, S. X., Li, W. X., Li, G. H. & Huang, J. F. Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin. PeerJ 4, e1791 (2016).
4. Shapiro, P. A promiscuous kinase inhibitor reveals secrets to cancer cell survival. J. Biol. Chem. 294, 8674–8675 (2019).
5. Bowes, J. et al. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat. Rev. Drug Discov. 11, 909–922 (2012).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献